
A Progress Report on Psychedelic Drug Legislation in Connecticut and Nearby States
The burgeoning field of psychedelic medicine, which suffered a major setback last year when the Food and Drug Administration (FDA) rejected an application to approve the use of midomafetamine (MDMA) to treat post-traumatic stress disorder (PTSD), has …